申请人:Ali Amjad
公开号:US20100298277A1
公开(公告)日:2010-11-25
A compound having the structure
wherein R is an angiotensin receptor blocking group
Y is —(CR
1
R
20
)
1-7
R
5
, or —C(O)(CR
1
R
20
)
1-7
R
5
;
R
1
and R
20
are independently selected from the group consisting of hydrogen or C
1-4
alkyl;
R
5
is —O—N═N(O)—NR
3
R
4
; and
R
3
and R
4
are independently selected from the group consisting of —CH
2
CH
2
OH, —CH
2
CH
2
OCH
3
, —C
1-4
alkyl, unsubstituted or substituted C
1-6
alkenyl, unsubstituted or substituted morpholino, amino, unsubstituted or substituted benzyl, unsubstituted or substituted phenyl, unsubstituted or substituted arylC
1-4
alkyl,
or R
3
and R
4
together with the nitrogen atom to which they are attached, form a ring selected from the group consisting of
or a stereoisomer thereof, or a pharmaceutically acceptable salt thereof, or a pharmaceutically acceptable salt of the stereoisomer thereof, which is useful for treating hypertension.